BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Colorcon
AstraZeneca
Mallinckrodt
Daiichi Sankyo
Chubb
Accenture
Cerilliant
McKinsey

Generated: January 21, 2018

DrugPatentWatch Database Preview

DEPO-PROVERA Drug Profile

« Back to Dashboard

When do Depo-provera patents expire, and when can generic versions of Depo-provera launch?

Depo-provera is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in DEPO-PROVERA is medroxyprogesterone acetate. There are nineteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.

US Patents and Regulatory Information for DEPO-PROVERA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 012541-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 020246-001 Oct 29, 1992 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 012541-003 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for DEPO-PROVERA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 012541-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 012541-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
US Army
Moodys
QuintilesIMS
Johnson and Johnson
Medtronic
Deloitte
Dow
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot